Sign in
Taking peopleNo phase

Potassium-Competitive Acid Blocker Versus Proton Pump Inhibitor as A Part of Bismuth Based Quadruple Therapy for Treatment of Helicobacter Pylori Infection

Key facts

Who runs it
Tanta University
Where
Egypt1 site in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
320 people, planned
Started
11 Sept 2025
Planned end
1 Feb 2026
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Potassium-Competitive Acid Blocker
  • Proton Pump Inhibitor
Record updated
12 September 2025

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 10 criteriaShow less

Who can take part

  • Adults aged ≥18 years
  • Both sexes
  • Confirmed Helicobacter pylori infection by stool antigen (3rd-gen ELISA) or urea breath test (UBT)
  • No prior eradication therapy

Who cannot take part

  • Prior Helicobacter pylori treatment
  • Use of antibiotics, proton pump inhibitor, or bismuth in the prior 4 weeks
  • Gastric surgery history
  • Major organ failure
  • Known allergy to study drugs
  • Pregnancy or lactation

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This study aims to compare the eradication rate, safety, and patient adherence between potassium-competitive acid blockers (P-CABs) and proton pump inhibitor-based bismuth quadruple therapy in patients with Helicobacter pylori infection.

The 2 groups in the trial

  • B-CAP groupTreatment being tested

    Patients will a 10-day course of bismuth, metronidazole, tetracycline four times daily, and vonoprazan 20 mg twice daily.

    Treatment: Potassium-Competitive Acid Blocker

  • PPI groupExisting treatment, for comparison

    Patients will receive a 10-day course of bismuth, metronidazole, tetracycline four times daily, and rabeprazole 20 mg twice daily.

    Treatment: Proton Pump Inhibitor

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Potassium-Competitive Acid Blocker Versus Proton Pump Inhibitor as A Part of Bismuth Based Quadruple Therapy for Treatment of Helicobacter Pylori Infection: A Randomized Controlled Trial
Record updated
12 September 2025